Frontlight ResearchEarly access
Trial site
SANA Kliniken Oberfranken Coburg GmbH
- 9running trials
- 2closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Atrial fibrillation4 trials
- Coronary artery disease2 trials
- High blood pressure2 trials
- Stroke2 trials
- Chronic kidney disease1 trial
- Heart failure1 trial
- Obesity1 trial
- Peripheral artery disease1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 38 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Recruiting6 trials
- Active, not recruiting3 trials
- Completed2 trials
- Lead sponsor
- Janssen Research & Development, LLC2 trials
- Novo Nordisk A/S2 trials
- Acesion Pharma1 trial
- Boehringer Ingelheim1 trial
- Boston Scientific Corporation1 trial
- and 4 more
Running trials
Recruiting
Active, not recruiting
Recruiting
SGLT2 Inhibition for Cardiovascular Endpoint Reduction in Hypertension
Recruiting
Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
Recruiting
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation2 recruiting
- High blood pressure2 recruiting
- Heart failure1 recruiting
- Obesity1 recruiting
- Peripheral artery disease1 recruiting
- Stroke1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026